Inflammatory bowel disease

Adolescent Medicine Clinics

Volumn 15, Issue 1, 2004, Pages 67-90

  Fish, Daryl ^a   Kugathasan, Subra ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOSALICYLIC ACID DERIVATIVE; ANTIBIOTIC AGENT; AZATHIOPRINE; BALSALAZIDE; BUDESONIDE; CIPROFLOXACIN; CORTICOSTEROID; CYCLOSPORIN; ETHINYLESTRADIOL; HYDROCORTISONE; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; METHYLPREDNISOLONE; METHYLPREDNISOLONE SODIUM SUCCINATE; METRONIDAZOLE; PREDNISOLONE; PREDNISONE; PROBIOTIC AGENT; SALAZOSULFAPYRIDINE; TESTOSTERONE ESTER;

ABDOMINAL PAIN; ACNE; ANTIINFLAMMATORY ACTIVITY; ARTHRALGIA; ARTHRITIS; BONE MARROW SUPPRESSION; CATARACT; CHRONIC DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; COLITIS; CROHN DISEASE; DELAYED PUBERTY; DIARRHEA; DRUG COST; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG METABOLISM; DRUG POTENCY; DRUG SAFETY; ENTERITIS; FEVER; GENETICS; GROWTH DISORDER; GROWTH RETARDATION; HEADACHE; HEMATOCHEZIA; HEPATITIS; HIRSUTISM; HUMAN; IMMUNITY; IMMUNOASSAY; INFECTION; LIVER TOXICITY; MICROFLORA; MOOD DISORDER; MOON FACE; MOUTH ULCER; MUCOSA INFLAMMATION; MYALGIA; OPPORTUNISTIC INFECTION; OSTEOPENIA; PANCREATITIS; PATHOGENESIS; PNEUMONIA; PSYCHOSIS; RASH; RECTUM DISEASE; RECTUM HEMORRHAGE; RECURRENT DISEASE; REVIEW; SIDE EFFECT; SINGLE DRUG DOSE; TOXICITY; ULCERATIVE COLITIS; WEIGHT GAIN; WEIGHT REDUCTION;

EID: 3142751966     PISSN: 15473368     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.admecli.2003.11.012     Document Type: Review

References (74)

1. Shashinder H, Integlia MJ, Grand RJ. Clinical manifestations of pediatric inflammatory bowel disease. 5th edition. Philadelphia: WBSaunders Company; 2000.
2. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998;115:182-205.
3. Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002;347:417-29.
4. Shanahan F. Inflammatory bowel disease: immunodiagnostics, immunotherapeutics, and ecotherapeutics. Gastroenterology 2001;120:622-35.
5. Sandler RS. Epidemiology of inflammatory bowel disease. In: Targan SR, Shanahan F, editors. Inflammatory bowel disease; from bench to bedside. Baltimore: Williams & Wilkins; 1994. p. 5-30.
6. Sonnenberg A, McCarty DJ, Jacobsen SJ. Geographic variation of inflammatory bowel disease within the United States. Gastroenterology 1991;100:143-9.
7. Barton JR, Gillon S, Ferguson A. Incidence of inflammatory bowel disease in Scottish children between 1968 and 1983; marginal fall in ulcerative colitis, three-fold rise in Crohn's disease. Gut 1989;30:618-22.
8. Calkins BM, Lilienfeld AM, Garland CF, et al. Trends in incidence rates of ulcerative colitis and Crohn's disease. Dig Dis Sci 1984;29:913-20.
9. Cho JH. Update on the genetics of inflammatory bowel disease. Curr Gastroenterol Rep 2001;3:458-63.
10. Armitage E, Drummond HE, Wilson DC, et al. Increasing incidence of both juvenile-onset Crohn's disease and ulcerative colitis in Scotland. Eur J Gastroenterol Hepatol 2001;13:1439-47.
11. Sawczenko A, Sandhu BK, Logan RF, et al. Prospective survey of childhood inflammatory bowel disease in the British Isles. Lancet 2001;357:1093-4.
12. Kugathasan S, Judd RH, Hoffmann RG, et al. Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in Wisconsin: a statewide population-based study. J Pediatr 2003;143:525-31.
13. Bonen DK, Cho JH. The genetics of inflammatory bowel disease. Gastroenterology 2003;124:521-36.
14. Griffiths AM, Thijs G, Siverberg MS. Role of NOD2/CARD15 variants in pediatric Crohn's disease. Inflamm Bowel Dis 2003;9:S30.
15. Zhou Z, Lin XY, Akolkar PN, et al. Variation at NOD2/CARD15 in familial and sporadic cases of Crohn's disease in the Ashkenazi Jewish population. Am J Gastroenterol 2002;97:3095-101.
16. Umesaki Y, Setoyama H, Matsumoto S, et al. Expansion of alpha beta T-cell receptor-bearing intestinal intraepithelial lymphocytes after microbial colonization in germ-free mice and its independence from thymus. Immunology 1993;79:32 -7.
17. Butler JE, Sun J, Weber P, et al. Antibody repertoire development in fetal and newborn piglets, III. Colonization of the gastrointestinal tract selectively diversifies the preimmune repertoire in mucosal lymphoid tissues. Immunology 2000;100:119-30.
18. Swidsinski A, Ladhoff A, Pernthaler A, et al. Mucosal flora in inflammatory bowel disease. Gastroenterology 2002;122:44-54.
19. Hampe J, Cuthbert A, Croucher PJ, et al. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 2001;357:1925-8.
20. Baldassano RN, Piccoli DA. Inflammatory bowel disease in pediatric and adolescent patients. Gastroenterol Clin North Am 1999;28:445-58.
21. Griffiths AM, Nguyen P, Smith C, et al. Growth and clinical course of children with Crohn's disease. Gut 1993;34:939-43.
22. Gryboski JD. Crohn's disease in children 10 years old and younger: comparison with ulcerative colitis. J Pediatr Gastroenterol Nutr 1994;18:174.
23. Hyams JS, Davis P, Grancher K, et al. Clinical outcome of ulcerative colitis in children. J Pediatr 1996;129:81-8.
24. Katz JA. Medical and surgical management of severe colitis. Semin Gastrointest Dis 2000;11:18-32.
25. Stephens M, Batres LA, Ng D, Baldassano R. Growth failure in the child with inflammatory bowel disease. Semin Gastrointest Dis 2001;12:253-62.
26. Motil KJ, Grand RJ, Davis-Kraft L, et al. Growth failure in children with inflammatory bowel disease: a prospective study. Gastroenterology 1993;105:681-91.
27. Sentongo TA, Semeao EJ, Piccoli DA, et al. Growth, body composition, and nutritional status in children and adolescents with Crohn's disease. J Pediatr Gastroenterol Nutr 2000;31:33-40.
28. Griffiths AM. Enteral nutrition: the neglected primary therapy of active Crohn's disease. J Pediatr Gastroenterol Nutr 2000;31:3-5.
29. Azcue M, Rashid M, Griffiths A, et al. Energy expenditure and body composition in children with Crohn's disease: effect of enteral nutrition and treatment with prednisolone. Gut 1997;41:203-8.
30. Ballinger A. Fundamental mechanisms of growth failure in inflammatory bowel disease. Horm Res 2002;58(Suppl 1):7-10.
31. Ferguson A, Sedgwick DM. Growth failure in pediatric IBD. J Pediatr Gastroenterol Nutr 1994;18:504-5.
32. Ferguson A, Sedgwick DM. Juvenile onset inflammatory bowel disease: height and body mass index in adult life. BMJ 1994;308:1259-63.
33. Ballinger AB, Savage MO, Sanderson IR. Delayed puberty associated with inflammatory bowel disease. Pediatr Research 2003;53:205-10.
34. Sentongo TA, Stettler N, Christian A, et al. Growth after intestinal resection for Crohn's disease in children, adolescents, and young adults. Inflamm Bowel Dis 2000;6:265-9.
35. Tolia V. Perianal Crohn's disease in children and adolescents. Am J Gastroenterol 1996;91:922-6.
36. Isaacs D, Wright VM, Shaw DG, et al. Chronic granulomatous disease mimicking Crohn's disease. J Pediatr Gastroenterol Nutr 1985;4:498-501.
37. Chung CC, Choi CL, Kwok SP, et al. Anal and perianal tuberculosis: a report of three cases in 10 years. J R Coll Surg Edinb 1997;42:189-90.
38. Seo JK, Yeon KM, Chi JG. Inflammatory bowel disease in children - clinical, endoscopic, radiologic and histopathologic investigation. J Korean Med Sci 1992;7:221-35.
39. Markowitz J, Grancher K, Rosa J, et al. Highly destructive perianal disease in children with Crohn's disease. J Pediatr Gastroenterol Nutr 1995;21:149-53.
40. Sellman SP, Hupertz VF, Reece RM. Crohn's disease presenting as suspected abuse. Pediatrics 1996;97:272-4.
41. Apgar JT. Newer aspects of inflammatory bowel disease and its cutaneous manifestations: a selective review. Semin Dermatol 1991;10:138-47.
42. Cabral DA, Malleson PN, Petty RE. Spondyloarthropathies of childhood. Pediatr Clin North Am 1995;42:1051-70.
43. Krasovec M, Frenk E. Acrodermatitis enteropathica secondary to Crohn's disease. Dermatology 1996;193:361-3.
44. Dupuy A, Cosnes J, Revuz J, et al. Oral Crohn disease: clinical characteristics and long-term follow-up of 9 cases. Arch Dermatol 1999;135:439-42.
45. Wilschanski M, Chait P, Wade JA, et al. Primary sclerosing cholangitis in 32 children: clinical, laboratory, and radiographic features, with survival analysis. Hepatology 1995;22:1415-22.
46. Kugathasan S, Halabi I, Telega G, et al. Pancreatitis as a presenting manifestation of pediatric Crohn's disease: a report of three cases. J Pediatr Gastroenterol Nutr 2002;35:96-8.
47. Ruemmele FM, Targan SR, Levy G, et al. Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease. Gastroenterology 1998;115:822-9.
48. Dubinsky MC, Ofman JJ, Urman M, et al. Clinical utility of serodiagnostic testing in suspected pediatric inflammatory bowel disease. Am J Gastroenterol 2001;96:758-65.
49. Ruuska T, Vaajalahti P, Arajarvi P, et al. Prospective evaluation of upper gastrointestinal mucosal lesions in children with ulcerative colitis and Crohn's disease. J Pediatr Gastroenterol Nutr 1994;19:181-6.
50. Charron M. Pediatric inflammatory bowel disease imaged with Tc-99m white blood cells. Clin Nucl Med 2000;25:708-15.
51. Seidman EG. Wireless capsule video-endoscopy: an odyssey beyond the end of the scope. J Pediatr Gastroenterol Nutr 2002;34:333-4.
52. Hyams JS, Ferry GD, Mandel FS, et al. Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr 1991;12:439-47.
53. Otley A, Smith C, Nicholas D, et al. The IMPACT questionnaire: a valid measure of healthrelated quality of life in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2002;35:557-63.
54. Faubion Jr WA, Loftus Jr EV, Harmsen WS, et al. The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology 2001;121:255-60.
55. Kundhal P, Zachos M, Holmes JL, et al. Controlled ileal release Budesonide in pediatric Crohn disease: efficacy and effect on growth. J Pediatr Gastroenterol Nutr 2001;33:75-80.
56. Sutherland L, Roth D, Beck P, et al. Oral 5-aminosalicylic acid for maintaining remission in ulcerative colitis. Cochrane Database Syst Rev 2002;(4):CD000544.
57. Hanauer SB, Dassopoulos T. Evolving treatment strategies for inflammatory bowel disease. Annu Rev Med 2001;52:299-318.
58. Present DH. 6-Mercaptopurine and other immunosuppressive agents in the treatment of Crohn's disease and ulcerative colitis. Gastroenterol Clin North Am 1989;18:57-71.
59. Kirschner BS. Safety of azathioprine and 6-mercaptopurine in pediatric patients with inflammatory bowel disease. Gastroenterology 1998;115:813-21.
60. Dubinsky MC, Lamothe S, Yang HY, et al. Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease. Gastroenterology 2000;118:705-13.
61. Markowitz J, Grancher K, Kohn N, et al. A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease. Gastroenterology 2000;119:895-902.
62. Mack DR, Young R, Kaufman SS, et al. Methotrexate in patients with Crohn's disease after 6-mercaptopurine. J Pediatr 1998;132:830-5.
63. Feagan BG, Rochon J, Fedorak RN, et al. Methotrexate for the treatment of Crohn's disease. The North American Crohn's Study Group Investigators. N Engl J Med 1995;332:292-7.
64. Hanauer SB, Feagan BG, Lichtenstein GR, et al. Maintenance infliximab for Crohn's disease: the ACCENT I randomized trial. Lancet 2002;359:1541-9.
65. Present DH, Rutgeerts P, Targan S, et al. Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med 1999;340:1398-405.
66. Hyams JS. Use of infliximab in the treatment of Crohn's disease in children and adolescents. J Pediatr Gastroenterol Nutr 2001;33(Suppl 1):S36-9.
67. Stephens MC, Shepanski MA, Mamula P, et al. Safety and steroid-sparing experience using infliximab for Crohn's disease at a pediatric inflammatory bowel disease center. Am J Gastroenterol 2003;98:104-11.
68. Griffiths AM, Ohlsson A, Sherman PM, et al. Meta-analysis of enteral nutrition as a primary treatment of active Crohn's disease. Gastroenterology 1995;108:1056-67.
69. Ruemmele FM, Roy CC, Levy E, et al. Nutrition as primary therapy in pediatric Crohn's disease: fact or fantasy? J Pediatr 2002;136:285-91.
70. Raine JE, Donaldson MDC, Gregory JW, et al. Practical endocrinology and diabetes in children. Oxford (United Kingdom): Blackwell Science; 2001. p. 54.
71. Andersson P, Olaison G, Bodemar G, et al. Surgery for Crohn colitis over a twenty-eight-year period: fewer stomas and the replacement of total colectomy by segmental resection. Scand J Gastroenterol 2002;37:68-73.
72. Baldassano RN, Han PD, Jeshion WC, et al. Pediatric Crohn's disease: risk factors for postoperative recurrence. Am J Gastroenterol 2001;96:2169-76.
73. Rintala RJ, Lindahl HG. Proctocolectomy and J-pouch ileo-anal anastomosis in children. J Pediatr Surg 2002;37:66-70.
74. Shamberger RC, Masek BJ, Leichtner AM, et al. Quality-of-life assessment after ileoanal pull-through for ulcerative colitis and familial adenomatous polyposis. J Pediatr Surg 1999;34:163-6.